Stringer, M., Goodlett, C. R., & Roper, R. J. (2017). Targeting trisomic treatments: Optimizing Dyrk1a inhibition to improve Down syndrome deficits. Molecular Genetics & Genomic Medicine, 5(5), 451. https://doi.org/10.1002/mgg3.334
Chicago Style (17th ed.) CitationStringer, Megan, Charles R. Goodlett, and Randall J. Roper. "Targeting Trisomic Treatments: Optimizing Dyrk1a Inhibition to Improve Down Syndrome Deficits." Molecular Genetics & Genomic Medicine 5, no. 5 (2017): 451. https://doi.org/10.1002/mgg3.334.
MLA (9th ed.) CitationStringer, Megan, et al. "Targeting Trisomic Treatments: Optimizing Dyrk1a Inhibition to Improve Down Syndrome Deficits." Molecular Genetics & Genomic Medicine, vol. 5, no. 5, 2017, p. 451, https://doi.org/10.1002/mgg3.334.